The U.S. Army is conducting market research on partnering to accelerate the development of technologies that will enable personnel to assess, protect and mitigate chemical and biological threats. This Request for Information [Read more]
Stony Brook University has been selected as one of eight institutions charged by the Department of Health and Human Services (HHS) with accelerating solutions to combat health security threats. Through the federal [Read more]
The U.S. Army for Medical Research Institute of Infectious Diseases (USAMRIID) has suspended Biosafety Level 3 (BSL-3) and Biosafety Level 4 (BSL-4) operations while conducting repairs to its waste treatment plant. Unprecedented [Read more]
Characterized by the World Health Organization as a “neglected tropical disease,” leprosy (also known as Hansen’s disease) is caused by Mycobacterium leprae. Nearly a quarter of a million people are diagnosed with [Read more]
The Department of Homeland Security (DHS) is seeking laboratory staffing support services for its BioWatch Laboratory Response Network (LRN) laboratories throughout the United States. Established in 2003, the mission of the BioWatch [Read more]
Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation, was the keynote speaker at the 128th annual Shattuck Lecture “Epidemics Going Viral: Innovation vs. Nature” on April 27. The event was [Read more]
The Experimental Therapeutics (ET) Branch of the Walter Reed Army Institute of Research (WRAIR) focuses on the development of new drugs to prevent and treat malaria, leishmaniosis, antibiotic-resistant bacteria, and other infectious [Read more]
The U.S. Navy is awarding funding to the Noguchi Memorial Institute for Medical Research in Ghana in support of infectious disease research in Western Africa. The contract is on behalf of the U.S. [Read more]
Health officials in Democratic Republic of Congo have reported 21 patients showing signs of hemorrhagic fever and 17 deaths in the affected area before an Ebola outbreak was confirmed today. Ground teams [Read more]
AntoXa Corporation has obtained a license from Defence Research & Development Canada (DRDC), an Agency of the Canadian Department of National Defence, to develop and produce an anti-ricin monoclonal antibody for sale [Read more]
© 2018 Global Biodefense